Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada · Delayed Price · Currency is CAD 8.25
-0.02 (-0.24%)
Dec 3, 2025, 4:00 PM EST
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 417.85 million as of December 4, 2025. Its market cap has increased by 172.79% in one year.
Market Cap
417.85M
Enterprise Value
336.13M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
8.25
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 417.85M, an increase of 435.66%. That is a compound annual growth rate of 42.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 2, 2025 | 418.86M | 160.72% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
| Mar 9, 2021 | 78.01M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.62B |
| dentalcorp Holdings | 2.18B |
| Green Thumb Industries | 2.11B |
| Sienna Senior Living | 1.92B |
| Extendicare | 1.72B |
| Trulieve Cannabis | 1.46B |
| Cronos Group | 1.31B |
| WELL Health Technologies | 977.45M |